Thousands of medical and healthcare workers, as well as scientists in life sciences and space, work in the US through H-1B visas. Indian doctors, physiotherapists and medical scientists looking at employment in the US are now left in limbo because the order does not clarify whether they are included according to new rules. Some examine different ways such as a visa depending on H-4 or J-1. All these people did not want to be quoted.
“Unlike the ban on traveling related to pandemia, when the US government indicated what visas or travel would be allowed as an exception to the national interest, this time there is no such indication,” Poorvi Chothani, immigration lawyer and control partner, Lawquest.
“Academics and healthcare professionals, including nurses, professional and physical therapists, etc., will have to wait for more clarity,” Chothani said. “From now on, their employers will have to pay $ 100,000 when submitting a new H-1B petition.”
One of the five immigrants in the US is, according to Indian origin, according to the analysis of data from the Institute of Migration Policy (MPI) and the Office for US Statistics. India was the second largest country for nurses in the US after the Philippines. In total, at 1.76 Lakhu, Indian health workers were 7% of the total population of immigrants.
Later on Friday, US President Donald Trump signed an executive order requiring companies to pay $ 100,000 for every new H-1B visa. The printing secretary of the White House Karoline Leavtt explained on Saturday that the fee is not an annual fee and would not have an impact on those who already hold H-1B visas and are currently outside the country.
Individuals employed by university institutions, non -profit organizations involved in research and persons involved in clinical education were previously exempt from paying fees.
H-1B visas allow companies to sponsor foreign workers with specialized skills such as the US in the US. Information technology employees will face the maximum impact when they corner the maximum number of such visas. However, healthcare professionals will not miss if the rules are alleviated for them.
“Quantum H-1B in this (medical) category will be less … it will certainly have an impact, but not as much as for technical staff,” said Bhan Prakash Kalmmat, partner and health industry in Thornton Bharat, Mint.
Aditya Narayan Misra, MD and CEO of Ciel HR recruitment company, said: “From now on healthcare staff fall into the same rules as IT managers falling under the H-1B visa.
According to a study published on Jama Network, American employers were certified to occupy approximately 10,500 H-1B doctors in 2017. It analyzed H-1B visa data from 2016 from the US Office for Foreign Working Certification. The H-1B applicants represented 1.4% of the active workforce in the country in the country that year.
Restrictions on the entry of immigrants could seriously burden the already tense US health care system, experts said.
Thousands of H-1B visions are used in the US in the US and the health care system would “accumulate at some time”, Dr. Satheesh Kathula, president of the American Association of Indian origin (AAPI), in an interview last year’s interview.
According to BIPLAB Lenin, Partner (Pharma, Healthcare & Life Sciences) in Cyril Amarchand Mangaldas, he said to Mint: “If the University Hospital or Medium Instituts suddenly have to take such a steep fee, he can think much twice before sponsoring international doctors.”
According to the annual report of US citizenship and immigration services FY24 on petitions H-1B, 23,560 applications for H-1B visa were earmarked in FY24 as part of FY24, as the employer was an employer of higher education institutions.
Almost 19,000 applications were exempt because the employer was a non -profit organization or a subject associated with a university institution; 6 598 because the employer was a non -profit organization of research or government organization; And more than 10,000 because the employer was a non -profit organization involved in clinical training.
GCC rise
Scientists from pharmaceutical and life sciences working for large pharmaceutical companies and biotechno -bikes could also find limited input unless exempt from increasing fees.
However, Kalmath of Thornton Bharat said it could lead to domestic growth of global capabilities (GCCS).
According to EY India report, India has already grown as a hub for the life of GCCS GCCS GCCS. Of the top 50 Global Life Sciences, 23 already operates GCC in India. While GCC Pharma processes more than 60% of functions such as finance, HR, supply chain, and is also increasingly accepting critical mandates across functions such as regulatory matters, medical and commercial, reporting in the report.
Talent in the country is huge: more than 2.7 million experts in the sector of life sciences. Every year, 2 million STEM graduates and more than 110,000 medical graduates enter the workforce.
(Tagstotranslate) H-1B Visa Healthcare (T) Indian doctors in the US
